|
WO2021081321A1
|
|
Systems and approaches for drug delivery
|
|
WO2021081263A1
|
|
Configurable handheld biological analyzers for identification of biological products based on raman spectroscopy
|
|
WO2021081326A1
|
|
Compositions and methods for minimizing protein loss at low protein concentrations
|
|
WO2021081283A1
|
|
Drug delivery device
|
|
WO2021081161A1
|
|
Systems and components for drug delivery and components for preparation of the same
|
|
WO2021081186A1
|
|
Drug delivery device and system
|
|
WO2021081204A1
|
|
Disruption of vascular smooth muscle relaxation by carfilzomib may be the primary reason for cfz-induced vascular dysfunction
|
|
WO2021081212A1
|
|
Pyridopyrimidine derivatives useful as kras g12c and kras g12d inhibitors in the treatment of cancer
|
|
WO2021076825A1
|
|
Systems and approaches for drug delivery device reconstitution
|
|
WO2021076826A2
|
|
Drug delivery device and system
|
|
WO2021076824A1
|
|
Systems and approaches for drug delivery device reconstitution
|
|
WO2021080828A1
|
|
Drug product container and drug delivery system
|
|
WO2021080822A1
|
|
Systems and methods for drug delivery
|
|
WO2021076655A1
|
|
Combination therapy of kras inhibitor and shp2 inhibitor for treatment of cancers
|
|
WO2021076540A1
|
|
Drug delivery device and system
|
|
WO2021071917A1
|
|
Cassette for an autoinjector and related methods
|
|
WO2021071886A1
|
|
Drug delivery device
|
|
WO2021071831A1
|
|
Packages for pharmaceutical products and methods of assembly
|
|
WO2021071771A1
|
|
Drug delivery device with fingerprint sensor
|
|
WO2021071780A1
|
|
Drug delivery devices having light-activated ultrasonic fluid delivery
|
